샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786727

세계의 히오신(Hyoscine) 시장

Hyoscine
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 281 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

히오신 세계 시장은 2030년까지 5억 440만 달러에 이를 전망

2024년에 4억 2,430만 달러로 추정되는 히오신 세계 시장은 2030년에는 5억 440만 달러에 이르고, 분석 기간인 2024-2030년 CAGR은 2.9%를 보일 것으로 예측됩니다. 히오신 브롬화 부틸 유형은 본 보고서에서 분석한 부문 중 하나이며, CAGR 2.3%를 나타내고, 분석 기간 종료시에는 3억 4,160만 달러에 이를 것으로 예측됩니다. 히오신 브롬화 수소산염 유형의 성장률은 분석 기간중 CAGR 4.3%로 추정됩니다.

미국 시장은 1억 1,560만 달러로 추정, 중국은 CAGR 5.4%로 성장 예측

미국의 히오신 시장은 2024년에 1억 1,560만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 9,780만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 5.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.2%와 2.2%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.6%를 나타낼 전망입니다.

세계의 히오신 시장 - 주요 동향과 촉진요인 정리

히오신이 현대 치료 현장에서 주목받는 이유는?

스코폴라민으로도 알려진 히오신은 구토억제, 진경제, 멀미 완화 작용을 위해 주로 사용되는 항콜린제로, 항콜린제 중 가장 잘 알려진 약품입니다. 중추신경계와 소화관의 무스카린 수용체를 차단하는 독특한 능력으로 메스꺼움, 구토, 위장 경련, 과민성 대장 증후군(IBS), 파킨슨병 관련 침 흘림 등 다양한 증상 관리에 효과적입니다. 평활근 관련 장애 및 운동 관련 메스꺼움에 대한 효과적인 비오피오이드 치료에 대한 수요가 증가함에 따라, 히오신은 수년 동안 임상적 관련성을 되찾고 있습니다. 수술이나 완화의료 장면에서 분비물 및 불편감 관리에 자주 사용되어 환자의 삶의 질을 향상시키고 있습니다. 또한, 소아 및 성인 인구의 여행 관련 멀미에 대한 인식이 높아짐에 따라 경피 흡수 패치 및 경구용 제제에 대한 수요가 증가하고 있습니다. 전 세계 헬스케어 시스템이 보다 개인화되고 증상별 맞춤 치료제로 전환되고 있는 가운데, 히오신은 다양한 용도와 빠른 작용 발현으로 의사와 의약품 개발자들 사이에서 다시 한 번 주목을 받고 있습니다.

제형 기술 혁신은 어떻게 히요틴 시장 용도를 확장하고 있는가?

제약 기술 혁신은 히오신 시장을 재편하고 있으며, 대체 전달 시스템과 환자 순응도 향상에 초점을 맞추었습니다. 기존의 경구제 및 주사제는 현재 경피 패치, 설하 정제, 비강 점안제, 협측 필름으로 보완되어 약물 방출이 더 잘 조절되고 작용 시간이 더 길어졌습니다. 특히 경피흡수형 패치는 며칠 동안 치료 효과를 지속시켜 멀미 예방에 혁명을 일으켜 장거리 여행이나 유람선 승객에게 이상적인 약품이 되었습니다. 나노 입자를 이용한 전달 및 표적 소화관 방출 시스템에 대한 최근 연구에서도 생체 이용률이 개선되어 히오신의 전신 부작용을 최소화하는 것으로 나타났습니다. 이러한 개발로 인해 약물의 내약성이 개선되고, 소아 및 노인용 제제로의 길이 열리고 있습니다. 또한, 히오신과 다른 구토방지제나 진경제와의 병용요법이 복잡한 위장병이나 신경질환의 치료를 위해 연구되고 있습니다. 이러한 첨단 제제가 주류 의료에 통합됨에 따라 히오신 시장 잠재력은 다양한 환자군과 임상적 요구에 따라 크게 확대되고 있습니다.

시장 역학에 영향을 미치는 규제 및 임상 개발이란?

규제 당국의 승인, 특허 활동, 임상 연구 이니셔티브는 세계 시장 상황경쟁 구도를 형성하고 있습니다. 미국 FDA, EMA, 신흥 시장 국가 기관 등 규제 기관은 새로운 히오스틴 기반 치료제, 특히 멀미, 수술 후 회복, 완화 치료를 위해 고안된 경피 및 비강 내 약물에 대한 승인을 계속하고 있습니다. 히오신은 강력한 안전성 프로파일과 수십 년간의 임상 사용 경험을 바탕으로 새로운 약물 및 장치 조합에 포함될 때 종종 신속한 규제 경로를 누릴 수 있습니다. 동시에 알츠하이머병, 파킨슨병 관련 침 흘림, 마취 후 섬망 등 신경 질환에 대한 임상 연구 증가는 새로운 치료 카테고리로의 확장을 시사하고 있습니다. 전 세계 약물감시 데이터는 히오신의 유효성과 안전성을 지속적으로 입증하고 있으며, 임상의들 사이에서 그 가치를 인정받고 있습니다. 이와 병행하여, 시장 업체들은 전달 기술 향상과 적응증 확대에 투자하여 규제 독점권 및 라이프사이클 관리 전략을 추구하고 있습니다. 임상시험과 제품 혁신 파이프라인 증가는 혼잡한 항경련제 및 구토제 시장에서 제조업체들이 제품을 차별화할 수 있도록 돕고 있습니다.

히오신 시장의 성장 촉진요인은 무엇인가?

히오신 시장의 성장은 약물의 재제형화, 최종 사용자 수요, 치료의 다양성, 세계 건강 동향 등 여러 가지 요인으로 인해 발생합니다. 첫째, 선진국과 신흥국 모두 멀미와 위장장애의 발생률이 증가하고 있으며, 즉각적이고 내약성이 좋은 대증요법에 대한 수요가 증가하고 있습니다. 둘째, 특히 북미, 유럽, 일본의 고령화 인구 증가로 인해 완화 치료, 파킨슨병 관리, 수술 후 증상 완화 등 히오신 기반 제품에 대한 수요가 증가하고 있습니다. 셋째, 소비자 건강 시장에서 시판되는 히오스틴 제품의 가용성이 증가함에 따라, 특히 여행과 관련된 용도에서 처방전 없이도 사용할 수 있는 범위가 확대되고 있습니다. 넷째, 패치, 점비제, 서방형 정제 등 약물 전달 시스템의 발전은 환자의 순응도와 치료 효과를 향상시켜 다양한 계층에 히오스틴을 어필하고 있습니다. 다섯째, 제약기업들은 지역 시장 확대에 적극적으로 투자하고 있으며, 특히 아시아태평양과 라틴아메리카에서 소화기 및 중추신경계 치료제에 대한 수요가 빠르게 증가하고 있습니다. 마지막으로, 강력한 임상적 증거, 진행 중인 연구 및 규제 환경의 지원으로 인해 세계 제약 산업에서 신뢰할 수 있고, 적응성이 높으며, 점점 더 혁신적인 치료 옵션으로 자리매김하고 있습니다.

부문

유형(히오신 브롬화 부틸 유형, 히오신 브롬화수소산염 유형), 투여(경구 투여, 패치 투여, 주사 투여)

조사 대상 기업 예

  • Actylis
  • AdvaCare Pharma
  • Alchem International Pvt. Ltd
  • Aspen API
  • Atman Pharmaceuticals
  • Baxter International Inc.
  • Bazayan & Co
  • Biotechnica DWC
  • Caleb Pharmaceuticals Inc.
  • GlaxoSmithKline plc(GSK)
  • Jai Radhe Sales
  • LGM Pharma
  • Linnea SA
  • MYUNGMOON PHARM CO., LTD.
  • Perrigo Company plc
  • Phytex Australia
  • Rumit Group of Companies
  • Sarv Biolabs Pvt. Ltd
  • Transo-Pharm Handels GmbH
  • Zhejiang Ausun Pharmaceutical Co., Ltd.

AI 통합

당사는 검증 끝난 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.14

Global Hyoscine Market to Reach US$504.4 Million by 2030

The global market for Hyoscine estimated at US$424.3 Million in the year 2024, is expected to reach US$504.4 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Hyoscine Butyl Bromide Type, one of the segments analyzed in the report, is expected to record a 2.3% CAGR and reach US$341.6 Million by the end of the analysis period. Growth in the Hyoscine Hydrobromide Type segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$115.6 Million While China is Forecast to Grow at 5.4% CAGR

The Hyoscine market in the U.S. is estimated at US$115.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$97.8 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.2% and 2.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Hyoscine Market - Key Trends & Drivers Summarized

Why Is Hyoscine Regaining Focus in Modern Therapeutic Practices?

Hyoscine, also known as scopolamine, is a well-established anticholinergic drug used primarily for its antiemetic, antispasmodic, and motion sickness-relieving properties. Its unique ability to block muscarinic receptors in the central nervous system and gastrointestinal tract makes it effective in managing a wide range of conditions, including nausea, vomiting, gastrointestinal cramps, irritable bowel syndrome (IBS), and Parkinson’s-related drooling. Over the years, hyoscine has regained clinical relevance due to the growing demand for effective non-opioid treatments for smooth muscle-related disorders and motion-related nausea. In surgical and palliative care settings, it is frequently used to manage secretions and discomfort, enhancing patient quality of life. Moreover, the rising awareness of travel-related motion sickness in both pediatric and adult populations has fueled demand for transdermal hyoscine patches and oral formulations. As global healthcare systems shift towards more personalized and symptom-targeted therapeutics, hyoscine is seeing renewed interest among physicians and pharmaceutical developers for its diverse applications and rapid onset of action.

How Are Formulation Innovations Expanding Hyoscine's Market Applications?

Pharmaceutical innovations are reshaping the hyoscine market, with a strong emphasis on alternative delivery systems and improved patient adherence. Traditional oral and injectable forms are now complemented by transdermal patches, sublingual tablets, nasal sprays, and buccal films, which offer more controlled drug release and longer durations of action. The transdermal patch, in particular, has revolutionized the prevention of motion sickness by providing sustained therapeutic levels over several days, making it ideal for long-distance travel or cruise ship passengers. Recent research into nanoparticle-based delivery and targeted gastrointestinal release systems is also improving the bioavailability and minimizing systemic side effects of hyoscine. These developments are enhancing the drug’s tolerability and opening avenues for pediatric-friendly and geriatric-use formulations. Additionally, combination therapies that include hyoscine with other antinausea or antispasmodic agents are being investigated to treat complex gastrointestinal and neurological conditions. The integration of these advanced formulations into mainstream healthcare practice is significantly expanding hyoscine’s market potential across different patient demographics and clinical needs.

What Regulatory and Clinical Developments Are Influencing Market Dynamics?

Regulatory approvals, patent activity, and clinical research initiatives are shaping the competitive landscape of the global hyoscine market. Regulatory bodies such as the U.S. FDA, EMA, and national agencies in emerging markets continue to approve new hyoscine-based therapies, particularly transdermal and intranasal forms designed for motion sickness, postoperative recovery, and palliative care. With a strong safety profile and decades of clinical usage, hyoscine often enjoys expedited regulatory pathways when included in novel drug-device combinations. At the same time, increased clinical investigation into its use for neurological conditions-including Alzheimer's, Parkinson's-related drooling, and post-anesthesia delirium-signals an expansion into new therapeutic categories. Global pharmacovigilance data continues to support the efficacy and safety of hyoscine, strengthening its reputation among clinicians. In parallel, market players are pursuing regulatory exclusivity and lifecycle management strategies by investing in improved delivery technologies and expanding indications. The growing pipeline of clinical trials and product innovations is helping manufacturers differentiate offerings in a crowded antispasmodic and antiemetic market.

What Are the Key Drivers of Growth in the Hyoscine Market?

The growth in the hyoscine market is driven by several factors related to drug reformulation, end-user demand, therapeutic versatility, and global health trends. First, the rising incidence of motion sickness and gastrointestinal disorders in both developed and developing countries is increasing the demand for fast-acting, well-tolerated symptomatic treatments. Second, the growing aging population, particularly in North America, Europe, and Japan, is fueling demand for hyoscine-based products in palliative care, Parkinson's disease management, and postoperative symptom relief. Third, the increasing availability of over-the-counter hyoscine products in consumer health markets is expanding its reach beyond prescription-only settings, especially for travel-related applications. Fourth, advancements in drug delivery systems-such as patches, nasal sprays, and extended-release tablets-are boosting patient compliance and therapeutic efficacy, making hyoscine more appealing across multiple demographics. Fifth, pharmaceutical companies are actively investing in regional market expansion, especially in Asia-Pacific and Latin America, where demand for gastrointestinal and CNS-related therapies is rapidly rising. Lastly, strong clinical evidence, ongoing research, and regulatory support are solidifying hyoscine’s position in the global pharmaceutical landscape as a trusted, adaptable, and increasingly innovative therapeutic option.

SCOPE OF STUDY:

The report analyzes the Hyoscine market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Hyoscine Butyl Bromide Type, Hyoscine Hydrobromide Type); Administration (Oral Administration, Patches Administration, Injections Administration)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

  • Actylis
  • AdvaCare Pharma
  • Alchem International Pvt. Ltd
  • Aspen API
  • Atman Pharmaceuticals
  • Baxter International Inc.
  • Bazayan & Co
  • Biotechnica DWC
  • Caleb Pharmaceuticals Inc.
  • GlaxoSmithKline plc (GSK)
  • Jai Radhe Sales
  • LGM Pharma
  • Linnea SA
  • MYUNGMOON PHARM CO., LTD.
  • Perrigo Company plc
  • Phytex Australia
  • Rumit Group of Companies
  • Sarv Biolabs Pvt. Ltd
  • Transo-Pharm Handels GmbH
  • Zhejiang Ausun Pharmaceutical Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Hyoscine - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Motion Sickness and Gastrointestinal Disorders Throws the Spotlight on Hyoscine
    • Growing Demand for Antispasmodic Therapies Spurs Use of Hyoscine in Digestive and Urinary Applications
    • Expansion of OTC Drug Markets Strengthens the Business Case for Hyoscine-Based Motion Sickness Medications
    • Here's How Increasing Global Travel and Tourism Accelerates Demand for Transdermal and Oral Hyoscine Products
    • Growth in Geriatric Population Expands the Addressable Market for Hyoscine in Neurological and Palliative Care
    • Advancements in Drug Delivery Systems Drive Innovation in Buccal, Patch, and Sublingual Hyoscine Formulations
    • Here's the Story: Non-Invasive Delivery Preferences Fuel Adoption of Transdermal Scopolamine Patches
    • Rising Use in Preoperative and Postoperative Care Supports Market Demand in Hospital and Surgical Settings
    • Increased Clinical Research into CNS Disorders Strengthens Potential Use Cases in Alzheimer's and Parkinson's Symptom Management
    • Growing Demand for Anti-Nausea Medications in Oncology Drives Use of Hyoscine as Adjunct Therapy
    • Global Expansion of Generic Hyoscine Manufacturing Boosts Accessibility and Competitive Pricing
    • Evolving Consumer Preferences for Plant-Derived and Natural Compounds Align with Botanical Origin of Hyoscine
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hyoscine Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hyoscine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Hyoscine Butyl Bromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Hyoscine Butyl Bromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Hyoscine Butyl Bromide Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hyoscine Hydrobromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hyoscine Hydrobromide Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Hyoscine Hydrobromide Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Patches Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Patches Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Patches Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Injections Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Injections Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Injections Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • JAPAN
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • CHINA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • EUROPE
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Hyoscine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • FRANCE
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • GERMANY
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Hyoscine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • INDIA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Hyoscine by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Hyoscine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Hyoscine by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Hyoscine by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030
  • AFRICA
    • Hyoscine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Hyoscine by Type - Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Hyoscine by Type - Percentage Breakdown of Value Sales for Hyoscine Butyl Bromide Type and Hyoscine Hydrobromide Type for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Hyoscine by Administration - Oral Administration, Patches Administration and Injections Administration Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Hyoscine by Administration - Percentage Breakdown of Value Sales for Oral Administration, Patches Administration and Injections Administration for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제